4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-16-000138
Options or other derivatives
- Chief Scientific Officer acquired 225,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lotze Michael · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-03-28 | Grant or award : show line 1 in the form Stock Option (right to buy) | +225,000 | $4.54 | 2026-03-28 | 225,000 | 225,000 | D |
Loading xslF345X03/primary_doc.xml…